Table 2.
Number of patients | ccfDNA (ALU115) Median(range) (ng/μL) | P-value | P-value | Integrity (ALU247/ALU115) | P-value | P-value | |
---|---|---|---|---|---|---|---|
PCa | 0.001 | ||||||
Prostate volume | |||||||
<35 g (25 cc) | 5 | 49.09 | 0.956 | 0.33 | 0.368 | ||
35g (25 cc)–50g (70 cc) | 13 | 50.59 | 0.34 | ||||
≫50 g (70 cc) | 12 | 57.12 | 0.37 | ||||
BPH | |||||||
Prostate volume | |||||||
<35 g (25 cc) | 6 | 12.15 | 0.161 | 0.207 | 0.14 | 0.363 | |
35 g (25 cc)–50 g (70 cc) | 20 | 13.06 | 0.16 | ||||
≫50 g (70 cc) | 14 | 15.60 | 0.17 | ||||
Healthy subject | |||||||
Prostate volume | |||||||
<35 g (25 cc) | 27 | – | – | – | – | ||
35 g (25 cc)–50 g (70 cc) | 3 | ||||||
≫50 g (70 cc) | 0 |
Abbreviations: PCa, prostate cancer; BPH, benign prostate hypertrophy; ccfDNA, circulation cell-free DNA.